Picard Medical, Inc. (PMI) - Total Assets
Based on the latest financial reports, Picard Medical, Inc. (PMI) holds total assets worth $22.55 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore PMI debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Picard Medical, Inc. - Total Assets Trend (2022–2025)
This chart illustrates how Picard Medical, Inc.'s total assets have evolved over time, based on quarterly financial data. See PMI total equity for net asset value and shareholders' equity analysis.
Picard Medical, Inc. - Asset Composition Analysis
Current Asset Composition (December 2025)
Picard Medical, Inc.'s total assets of $22.55 Million consist of 91.9% current assets and 8.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 33.1% |
| Accounts Receivable | $623.00K | 2.8% |
| Inventory | $7.30 Million | 32.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $509.00K | 2.3% |
| Goodwill | $615.00K | 2.7% |
Asset Composition Trend (2022–2025)
This chart illustrates how Picard Medical, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see PMI company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Picard Medical, Inc.'s current assets represent 91.9% of total assets in 2025, an increase from 78.5% in 2022.
- Cash Position: Cash and equivalents constituted 33.1% of total assets in 2025, up from 1.0% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 7.0% in 2022.
- Asset Diversification: The largest asset category is inventory at 32.4% of total assets.
Picard Medical, Inc. Competitors by Total Assets
Key competitors of Picard Medical, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW
|
USA | $13.32 Billion |
|
DexCom Inc
NASDAQ:DXCM
|
USA | $6.63 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Corentec Co Ltd
KQ:104540
|
Korea | ₩175.16 Billion |
|
Adherium Ltd
AU:ADR
|
Australia | AU$4.16 Million |
Picard Medical, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.11 | 0.28 | 0.95 |
| Quick Ratio | 0.72 | 0.05 | 0.20 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.03 Million | $-25.53 Million | $-451.00K |
Picard Medical, Inc. - Advanced Valuation Insights
This section examines the relationship between Picard Medical, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.06 |
| Latest Market Cap to Assets Ratio | 0.62 |
| Asset Growth Rate (YoY) | 86.3% |
| Total Assets | $22.55 Million |
| Market Capitalization | $13.90 Million USD |
Valuation Analysis
Below Book Valuation: The market values Picard Medical, Inc.'s assets below their book value (0.62x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Picard Medical, Inc.'s assets grew by 86.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Picard Medical, Inc. (2022–2025)
The table below shows the annual total assets of Picard Medical, Inc. from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $22.55 Million | +86.25% |
| 2024-12-31 | $12.11 Million | +6.44% |
| 2023-12-31 | $11.37 Million | -26.33% |
| 2022-12-31 | $15.44 Million | -- |
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internatio… Read more